From Reuters.

Novo Nordisk will slash US list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 35% and 50% respectively starting next year, said the Danish drugmaker.
#novonordisk #wegovy #ozempic #health #News #Reuters #Newsfeed

Read the story here: https://reut.rs/4aJkQ00

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en